Please read our various and important legal information about using Our Website:
Chris gained his PhD at University College London studying proteins of the immune system and cancerous proteins of papillomaviruses. Since then he has been working in the biotechnology industry for over 20 years, specialising in the discovery of novel large molecules, such as peptides, proteins and antibodies for research, diagnostics and therapeutics. Much of this research has involved components of the body's immune system, a critical orchestrator of either disease prevention or disease progression.
As a CSO and CEO he has led teams of scientists in technology development and discovery, collaborating widely with the pharma industry, and as a consultant he has advised biotechnology and academic start-ups on both business and scientific strategy.
If you would like to find out more about partnering with XenoVida, please use the ENQUIRY button below.